ATRC's EnCompass Clamp receives a CE Mark, enabling European surgeons to access faster, simpler heart ablation in cardiac surgeries with advanced radiofrequency technology.
Ablation Technology MarketThe global ablation technology market is poised for significant growth, with projections indicating a compound annual growth rate (CAGR) of 8.9% during the forecast period.
For instance, a cardiac ablation may cause fatigue, chest pain, and heart palpitations for several days. After an endometrial ablation, it's possible to experience excessive bleeding and cramps. For ...
United States Radiofrequency Ablation Devices Market was valued at US$ 1,296.97 million in 2023 and is projected to attain a market size of US$ 3,312.40 million by 2032 at a CAGR of 11.24% during the ...
The Global non-opioid pain relief device market, which was valued at US$ 5,444.8 million in 2023, is expected to reach US$ 11,440.6 million by 2032, signaling a significant growth trajectory at a CAGR ...
15. Lindor had played only one inning over the past 10 games due to lower back pain, though he was on deck and ready to pinch hit when the Mets made the final out of their 5-1 loss to the Atlanta ...
Objective: Although radiofrequency ablation (RFA) is a safe and effective non-surgical treatment for benign ... the right lobe nodule was treated (8.4 kJ were delivered in 9 min and 56 sec for a total ...